A detailed history of Gf Fund Management Co. Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 8,371 shares of MRNA stock, worth $207,265. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,371
Previous 9,853 15.04%
Holding current value
$207,265
Previous $272 Million 20.46%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

SELL
$23.51 - $34.67 $34,841 - $51,380
-1,482 Reduced 15.04%
8,371 $216 Million
Q2 2025

Jul 21, 2025

SELL
$23.65 - $28.54 $12,605 - $15,211
-533 Reduced 5.13%
9,853 $272 Million
Q1 2025

Apr 28, 2025

BUY
$28.35 - $47.53 $40,682 - $68,205
1,435 Added 16.03%
10,386 $294 Million
Q4 2024

Feb 18, 2025

BUY
$36.85 - $63.93 $329,844 - $572,237
8,951 New
8,951 $372 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.69B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Gf Fund Management Co. Ltd. Portfolio

Follow Gf Fund Management Co. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gf Fund Management Co. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Gf Fund Management Co. Ltd. with notifications on news.